Effects of idazoxan, tolazoline, and yohimbine on xylazine-induced respiratory changes and central nervous system depression in ewes.
We compared the ability of 3 alpha 2-adrenoreceptor antagonists, idazoxan (0.05 mg/kg), tolazoline (2 mg/kg), and yohimbine (0.2 mg/kg) to reverse xylazine (0.3 mg/kg)-induced respiratory changes and CNS depression in 6 ewes. Once weekly, each ewe was given a random IV treatment of xylazine, followed in 5 minutes by either an antagonist or 0.9% NaCl solution. Xylazine alone caused recumbency for 54.2 +/- 5.3 minutes (mean +/- SEM). Xylazine also increased respiratory rate and decreased PaCO2 for at least 45 minutes, but did not significantly change arterial pH or PaCO2. Idazoxan and tolazoline were equally effective in reversing the respiratory actions of xylazine; however, yohimbine was less effective in reducing the respiratory rate and was ineffective in antagonizing the decreased PaO2. Idazoxan and tolazoline decreased the duration of xylazine-induced recumbency to 6.3 +/- 0.6 and 9.5 +/- 2.3 minutes, respectively, whereas yohimbine did not significantly change this effect of xylazine. Thus, at the dosages studied, idazoxan and tolazoline appeared to be more effective than yohimbine in reversing the respiratory and CNS depressant actions of xylazine in sheep.
Hsu
W H
WH
Department of Veterinary Physiology and Pharmacology, Iowa State, University, Ames 50011.
Hanson
C E
CE
Hembrough
F B
FB
Schaffer
D D
DD
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D001785:Blood Gas Monitoring, Transcutaneous / Q000662:veterinary; D002492:Central Nervous System Depressants / Q000494:pharmacology; D004146:Dioxanes / Q000494:pharmacology; D005260:Female; D019329:Idazoxan; D010100:Oxygen / Q000097:blood*; D011897:Random Allocation; D012119:Respiration / Q000187:drug effects*; D012756:Sheep / Q000502:physiology*; D013843:Thiazines / Q000037:antagonists & inhibitors*; D014043:Tolazoline / Q000494:pharmacology; D014991:Xylazine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D015016:Yohimbine / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D002492:Central Nervous System Depressants; D004146:Dioxanes; D013843:Thiazines; D014991:Xylazine; D015016:Yohimbine; D014043:Tolazoline; D010100:Oxygen; D019329:Idazoxan